American Journal of Clinical Oncology-Cancer Clinical Trials

Article	Citations
Efficacy and Safety of Pegylated Filgrastim as Primary Prophylaxis Following Pediatric Dose-intensive Chemotherapy	62
Validation of Spanish-Language Surveys Utilized for the Navigator-Assisted Hypofractionation (NAVAH) Program to Aid Hispanic-American Breast Cancer Patients	24
Death From Infection Among Patients Living With Cancer	24
The Prognostic Significance of the Depth of Cervical Stromal Invasion in Women With FIGO Stage II Uterine Endometrioid Carcinoma	21
The Landscape of Clinical Trials for Claudin18.2-Positive Gastric Cancer	19
Pharmacokinetics-Pharmacodynamics Modeling and Evaluation of Tumor Response to Bortezomib Proteasome Inhibitor in Waldenstrom Macroglobulinemia	19
Does Examined Lymph Node Count Influence Survival in Surgically Resected Early‑stage Pulmonary Typical Carcinoid Tumors?	16
Nomogram Predicting Grade ≥2 Acute Radiation Enteritis in Patients With Cervical Cancer Receiving Concurrent Chemoradiotherapy	15
Endpoint Governance and Reporting Transparency in Biomarker-Guided Oncology Trials	14
Clinical Outcomes and Safety Profile of Adagrasib in KRAS G12C-Mutated Solid Tumors	14
The Impact of Patient, Disease, and Social Determinants of Health on Receipt of Nonoperative Management for Patients With Rectal Adenocarcinoma	13
Third-line Treatment for Metastatic Triple-negative Breast Cancer	12
Efficacy and Prognostic Factors of Immune Checkpoint Inhibitors in the Treatment of Advanced Non-small Cell Lung Cancer	12
Lack of Impact of Expansion Size From Gross Tumor Volume to Planning Target Volume on Control Rates and Patterns of Recurrence in Fractionated Radiotherapy for WHO Grade 1 Meningiomas	11
Heart Disease Mortality After Primary Cancer Surgery in the United States	11
The Prognostic and Functional Impact of Sprouty 2 Expression in Non–small Cell Lung Cancer	11
Hypofractionated Radiation Therapy	10
Efficacy and Safety of Camrelizumab Plus Apatinib for Esophageal Squamous Cell Carcinoma	10
Executive Summary of the American Radium Society Appropriate Use Criteria for Management of Squamous Cell Carcinoma of the Cervical Esophagus	10
Beyond the Clinic	10
Patient Navigation for Cancer Care in Sub-Saharan Africa	10
Durable Responses in Patients With Advanced Cholangiocarcinoma on Sequential Dual-agent Immunotherapy After Progressing on Single-agent Immunotherapy	10
Secondary Breast Angiosarcoma After a Primary Diagnosis of Breast Cancer	9
Prospective Validation of An Inpatient Metastatic Spine Neoplasm Score To Assess the Optimal Radiation Therapy Intervention Modality	9
Effects of Adjuvant Chemotherapy on Early-onset Stage II Colon Cancer at Different Tumor Sites	9

SBRT vs. Y90	9
Outcome Predictors of Hardware Complications in Head and Neck Free Flap Reconstruction	9
Efficacy and Safety of Neoadjuvant Immunochemotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma	9
The Effect of Biomarkers on Clinical Trial Risk in Gastric Cancer	9
Trends in Primary Gallbladder Cancer Incidence and Incidence-based Mortality in the United States, 1973 to 2015	9
Outcomes of De Novo Oligometastatic Breast Cancer Treated With Surgery of Primary and Metastasis Directed Radiotherapy	8
ACR–ACNM–ARS–SNMMI Practice Parameter for the Performance of Therapy With Radium-223 Dichloride	8
ACR–ARS Practice Parameter for Radiation Oncology	8
Update on Chemoresistance Mechanisms to First-Line Chemotherapy for Gallbladder Cancer and Potential Reversal Strategies	8
Early Experience With Two-Fraction Spine Stereotactic Body Radiation Therapy in Treating Spinal Metastases	8
Impact of Maximum Point Dose Within the Planning Target Volume on Local Control of Nonsmall Cell Lung Cancer Treated With Stereotactic Body Radiotherapy	8
A Meta-analysis on Effects of Chimeric Antigen Receptor T-cell Therapy in Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia	8
Quantification of Postdiagnosis Cancer Patient Navigation	7
Disparities in Survival Outcomes Among Patients With Metastatic Melanoma in Texas	7
Crossover in Adjuvant Trastuzumab Trials	7
The Role of Lactate Metabolism in Tumors	7
Impact of Consensus Guidelines, Clinical Trials, and COVID-19 on Fractionation Practices for Node-negative Intact Breast Cancer	7
Early Cancer Screening Impressions of African-American Breast Cancer Patients Enrolled on the Navigator-Assisted Hypofractionation (NAVAH) Trial	7
Accuracy of Medical Oncology Prognosis for Metastatic Cancer Patients Evaluated for Enrollment Onto an Ongoing Randomized Clinical Trial	7
Why Basic Science Education Matters in Radiation Oncology	7
Disparities in Receipt of Adjuvant Immunotherapy among Stage III Melanoma Patients	7
The Role of the Quality of Relationship in Couples Facing Treatment for Breast Cancer	7
Treatment of Cutaneous Adnexal Carcinoma With Radiotherapy	7
Overactive Bladder Symptoms in Cancer Patients Undergoing Chemotherapy	6
Executive Summary of the American Radium Society (ARS) Appropriate Use Criteria (AUC) for Locoregional Gastric Adenocarcinoma	6
Laparoscopic Versus Abdominal Radical Hysterectomy for Cervical Cancer	6
Utilization and Survival Impact of Hypofractionated Radiotherapy in Stage I Non-small Cell Lung Cancer	6
Primary Central Nervous System Melanoma (pCNSM) and Treatment Protocols	6
Therapeutic Evaluation of Induction Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma With Low-risk N Stage	6
Treatment of Cancer Pain	6
Physician Assessment of ChatGPT and Bing Answers to American Cancer Society’s Questions to Ask About Your Cancer	6
Association Between Statin Exposure and Incidence and Prognosis of Prostate Cancer	6
Impact of Time From Diagnosis to Treatment Start on the Outcomes of Patients With Nonmetastatic Anal Squamous Cell Carcinoma	5
Incidence and Risk of Second Primary Malignancies After Treatment for Papillary Thyroid Cancer	5
Risk Factors for Immunotherapy-related Adverse Events (IrAE) in Patients Treated With Immune Checkpoint Inhibitors	5
Navigator-Assisted Hypofractionation (NAVAH) Phase I Clinical Trial of Breast Cancer Patients	5
Does Current Training in Radiation Oncology Prepare Radiation Oncologists to Optimally Manage Patients With Head and Neck Cancer?	5
Evaluating N-acetylcysteine as a Protective Agent Against Chemotherapy-induced Neuropathy in Breast Cancer	5
Brachial Plexus Constraints in Two-Fraction Spine Stereotactic Body Radiation Therapy	5
Liver Injury in Patients With Distal Esophageal Carcinoma After Precision Radiation Therapy	5
Intramedullary Nailing Versus Compound Plate Osteosynthesis in Pathologic Diaphyseal Humerus Fractures	5
Trends in Neoadjuvant Pembrolizumab Use in Triple-Negative Breast Cancer	5
The Best Interest	5
Long-Term Outcomes After Abdominal Radiation for Wilms Tumor	5
The Landscape of Clinical Trials for Targeting c-MET Therapy	5
Early Experience With Biologically Effective Dose-Comparable Short-Course Whole Brain Radiation Therapy for Metastatic Intracranial Disease	5
Sacituzumab Govitecan-hziy in Breast Cancer	5
Mortality Patterns of Esophageal Cancer in the United States	5
Predicting Factors for a Favorable Pathologic Response to Neoadjuvant Therapy in Esophageal Cancer	5
Laparoscopic Versus Abdominal Radical Hysterectomy	5

Impact of Pretreatment Weight Loss on Radiotherapy Utilization and Clinical Outcomes in Non–Small Cell Lung Cancer	4
American Radium Society (ARS) Appropriate Use Criteria (AUC) for Locoregional Gastric Adenocarcinoma	4
Evaluating the Safety and Efficacy of Adding Liver-Directed Radiation Therapy to Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma	4
The Balance and Imbalance of Microbial Communities	4
Evaluation of Control Arm Quality in Recent Radiation Oncology Randomized Clinical Trials	4
Three-Decade Trends and Future Projections of Malignant Skin Melanoma Burden in the United States and Globally	4
Deep Learning-Based Risk Factor Analysis for Accurate Prediction of Lung Cancer in High-Risk Populations	4
Prognostics of Systemic Malignancy ICD-O Topography and Morphology Types on Brain Metastases	4
The Concerning Disaggregation of Gender and Racial/Ethnicity Disparity Investigation at Recent ASCO Annual Meetings	4
Geospatial Mapping of Head and Neck Cancer Research	4
Prognostic Value of Lymph Node Parameters in Elderly Patients With Stage III Serous Ovarian Cancer Based on Competing Risk Model	4
Variation in Practice Patterns Among Radiation Oncologists Treating Oropharyngeal Cancers	4
Preoperative Computed Tomography Radiomics Analysis for Predicting Receptors Status and Ki-67 Levels in Breast Cancer	4
FDA-Approved Radiopharmaceuticals in Oncologic PET Imaging	4
Insurance Denial of Care for Randomized Controlled Trial-Eligible Patients	4
The microRNA-34 Family and Its Functional Role in Lung Cancer	4
Efficacy of Fibroblast Growth Factor Receptor Inhibitors (FGFRi) in Locally Advanced or Metastatic Cholangiocarcinoma With FGFR Fusions or Rearrangements	4
Prognostic Value of the Cutoffs for HALP in Endometrial Cancer	4
Targeted and Chemo-Free Approaches in HER2-Positive Early Breast Cancer	4
Metaplastic Breast Carcinoma	4
Impact of Chemotherapy on Financial Toxicity in African American Breast Cancer Patients	3
Long COVID in Cancer	3
Comorbidity and Risk of Complications and Readmissions Following Surgery for Patients With Renal Cell Carcinoma in the Military Health System	3
Efficacy and Safety of Antibody Drug Conjugates in Previously Treated Hormone Receptor Positive HER2 Negative (or Low) Metastatic Breast Cancer–A Systematic Review and Meta-Analysis	3
A Systematic Review of Conversion to Resectability in Unresectable Metastatic Colorectal Cancer Chemotherapy Trials	3
Correspondence Letter to “Does Current Training in Radiation Oncology Prepare Radiation Oncologists to Optimally Manage Patients With Head and Neck Cancer?”	3
Concurrent Use of Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive and HER2-low Metastatic Breast Cancer	3
Diagnosis of Malignant Pulmonary Nodules Using a Combination of Tumor-associated Autoantibodies and Computed Tomography	3
Proceedings of the American Radium Society® 104th Annual Meeting	3
Prognostic Value of Multiparameter Biomarkers in Pleural Effusion of Patients With Non-small Cell Lung Cancer for Predicting Survival Outcomes	3
Primary Synovial Sarcoma of the Abdomen and Pelvis	3
Salbutamol, a Short Acting Beta-2 Agonist, Reduces Risk and Improves Prognosis of Prostate Cancer	3
Five Fraction External Beam Partial Breast Irradiation	3
H-Index and Promotion in Academic Radiation Oncology	3
A Novel Nomogram for Predicting Breast Cancer–specific Survival in Male Patients	3
National Trends and Disparities in Mortality From Early-Onset Pancreatic Cancer in the United States, 1999 to 2020	3
Phase 1 Study of Bortezomib, Fludarabine, and Melphalan, With or Without Total Marrow Irradiation, as Allogeneic Hematopoietic Stem Cell Transplant Conditioning for High-risk or Relapsed/Refractory Mu	3
Dual Inhibition of HER2 and VEGF Pathways in Breast Cancer	3
Advancements in Diagnosis and Multimodal Treatment Strategies for Retroperitoneal Tumors	3
Beyond Treatment	3
A Phase I Trial of the ABCB1 Inhibitor, Oral Valspodar, in Combination With Paclitaxel in Patients With Advanced Solid Tumors	3
Efficacy and Safety of BRCA-targeted Therapy (Polyadenosine Diphosphate-ribose Polymerase Inhibitors) in Treatment of BRCA-mutated Breast Cancer	3
Practice Patterns of Surveillance in Sentinel Lymph Node-Positive Malignant Melanoma	3
How Did We Get Here? The Progression From Frame-Based to Frameless Intracranial Stereotactic Radiosurgery	3
Efficacy and Safety of Probiotics as Adjunctive Therapy in Cancer Treatment	3
Social Determinants of Health in Oncology	3
Prevalence and Development of Cachexia Before and After Diagnosis of Non–small Cell Lung Cancer	3
Local Recurrence Outcomes of Colorectal Cancer Oligometastases Treated With Stereotactic Ablative Radiotherapy: Erratum	3
Transcranial Magnetic Stimulation (TMS) in Cancer Care	3
Clinicopathological Characteristics, Survival and Prognostic Factors in Gastrointestinal Large Cell Neuroendocrine Carcinoma	3
Executive Summary of the American Radium Society Appropriate Use Criteria	3
Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After Hepatocellular Carcinoma Liver Transplantation	3
A Preliminary Study of Immediate Intraperitoneal Chemotherapy for Stage III Colorectal Cancer	2
Comparison of Tumor Bed Delineation Using a Novel Radiopaque Filament Marker Versus Surgical Clips for Targeting Breast Cancer Radiotherapy	2
Real-world Safety of Concurrent Pembrolizumab and Radiotherapy in Triple-negative Breast Cancer	2
Decision-making for Subsequent Therapy for Patients With Recurrent or Advanced Endometrial Cancer Based on the Platinum-free Interval	2
Treatment of Internal Mammary Nodes is Associated With Improved Overall Survival in Breast Cancer	2
Stereotactic Body Radiation Therapy for Sarcoma Pulmonary Metastases	2
Accelerated Partial Breast Irradiation	2
The Significance of the Redox Gene in the Prognosis and Therapeutic Response of Glioma	2
The Impact of Race and Ethnicity on Location and Delivery of Palliative Radiotherapy	2
Predictors of an Academic Career in Radiation Oncology 5 to 10 Years After Residency	2
Prognostic Value of Pretreatment Serum Carcinoembryonic Antigen Level in 1130 Patients With Non-small Cell Lung Cancer	2
Development and Validation of Palmitoylation-Related Genes in the Prognostic and Immunologic Characterization of Lung Adenocarcinoma	2
Bombarding Oligoprogression	2
Treatment Patterns of Bone-targeting Agents Among Solid Tumor Patients With Bone Metastases	2
Divergent Biliary Tract Cancer Trajectories	2
Efficacy and Toxicity of Combined Inhibition of EGFR and VEGF in Patients With Advanced Non–small Cell Lung Cancer Harboring Activating EGFR Mutations	2
The Role of Social Determinants of Health in the Receipt of Systemic Treatment for Metastatic Melanoma	2
The Cost of Simplicity for Early-stage Breast Cancer Treatment	2
Racial Disparities in Endometrial Cancer Clinical Trial Representation	2
Clinical Features, Treatment Patterns, and Outcomes of Solitary Plasmacytoma in the United States	2
Validation of CTS5 Model in Large-scale Breast Cancer Population and Combination of CTS5 and Ki-67 Status to Develop a Novel Nomogram for Prognosis Prediction	2
The Brown University Oncology Group Experience With FOLFOX + Nab-paclitaxel [FOLFOX-A] for Metastatic and Locally Advanced Pancreatic, BrUOG-292 and BrUOG-318	2
Circulating DNA in Rectal Cancer to Unravel the Prognostic Potential for Radiation Oncologist	2
Long-term Locoregional Control With Unilateral Radiation for AJCC-7 T1-2N2b Tonsillar Cancer	2
Efficacy of Sacituzumab Govitecan in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer	2
Correlation of Lung Immune Prognostic Index With Efficacy of PD-1/PD-L1 Inhibitor Combined With Chemotherapy and Prognosis in Patients With Advanced Non–Small Cell Lung Cancer	2
The Effect of PD-1/PD-L1 Inhibitor and Statin Combination Therapy on Overall Survival and Gastrointestinal Toxicity	2
ACR–ARS Practice Parameter for the Performance of Stereotactic Body Radiation Therapy	2

Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum	2
Advancing MRD Detection in Multiple Myeloma	2
Sentinel Node Navigation Surgery for Early Gastric Cancer	2
Meta-analysis of Therapeutic Approaches in Acute Myeloid Leukemia	2
Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy	2
Complications of Implant-Based Reconstruction and Postmastectomy Radiation in the Era of Adjuvant CDK4/6 Inhibitors	2
Treatment of Recurrent Low-grade Serous Ovarian Cancer With MEK Inhibitors	2
Efficacy and Safety of Abemaciclib in Combination With Endocrine Therapy for HR+/HER2− Advanced or Metastatic Breast Cancer	2
Impact of Minimal Residual Diseases Status and Depth of Response on Survival Outcomes in Blinatumomab-Treated Acute Lymphoblastic Leukemia	2
Prognostic Relevance of Negative Lymph Node Count in Resected Stage I–IIIa Small-cell Lung Cancer	2
Regional Variation in Access to Oncologic Care and Racial Disparities Among Cervical Cancer Patients	2
Surveillance Strategies in Follicular Non-Hodgkin’s Lymphoma’s Using Molecular and Genetic Markers Improve Cost-efficiencies Over Routine Imaging Studies	2
An Online Model for Central Lymph Node Metastases in Papillary Thyroid Carcinoma With BRAF V600E Mutation	2
Effect of Continuous Nutritionist-led Guidance on Bowel Preparation in Patients Undergoing Prostate Stereotactic Body Radiation Treatment With Endorectal Spacing	2
Assessing the Rate and Quality of Breast Cancer Treatment Following Initial Diagnosis	2
Standard Versus Extended Pelvic Lymphadenectomy in Patients With Bladder Cancer	2
KRAS Mutations in Cancer	2
Tumor Volume Predicts for Pathologic Complete Response in Rectal Cancer Patients Treated With Neoadjuvant Chemoradiation	2
ACR–ABS–ACNM–ARS–SIR–SNMMI Practice Parameter for Radioembolization of Liver Malignancies	2
Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor–targeted Therapy	2
Flap Reconstruction Results in Longer Overall Treatment Time in Patients Treated With Surgery and Adjuvant Radiotherapy for Carcinoma of the Oral Cavity and Larynx	2
Matched Cohort Analysis of Ultra-hypofractionated Versus Standard Fractionation Preoperative Radiation Therapy for Soft Tissue Sarcoma	2
Impact of Interruptions in Chemotherapy on Survival for Patients With Metastatic or Recurrent Cervical Cancer	1
Safety and Efficacy of Trastuzumab Deruxtecan for Metastatic HER2+ and HER2-low Breast Cancer	1
Addition of External Beam Radiation Therapy to Adjuvant Chemotherapy for Patients With Stage IIIC Uterine Endometrioid Carcinoma: Utilization and Outcomes	1
A Phase II Trial to Assess the Evolution of the KRAS Mutation Load by Liquid Biopsy in Patients With Resectable Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant NALIRIFOX	1
Targeted Therapies in Non–Small Cell Lung Cancer	1
Metabolic Plasticity in Prostate Cancer	1
Neoadjuvant Therapy Regimens for Hilar Cholangiocarcinoma Before Liver Transplant	1
Maintenance Therapy in Acute Myeloid Leukemia	1
Recurrence Risk Stratification for Women With FIGO Stage I Uterine Endometrioid Carcinoma Who Underwent Surgical Lymph Node Evaluation	1
Global Trends in Childhood Acute Lymphoblastic Leukemia Burden and Quality of Care Inequalities Across Regions, 1990 to 2021	1
Prostate Brachytherapy With Cs-131	1
American Radium Society (ARS) Appropriate Use Criteria (AUC) for Extrahepatic Cholangiocarcinoma	1
Efficacy and Safety of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma	1
Cardiovascular Risk Profile of Nivolumab Anti-cancer Therapy	1
Wilms’ Tumor 1-Associating Protein Promotes Nonsmall-Cell Lung Cancer Through the Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5	1
Advancements in NSCLC	1
ACR–ARS Practice Parameter for the Performance of Total Body Irradiation	1
The Impact of Psychedelic Drugs on Anxiety and Depression in Advanced Cancer or other Life-threatening Disease	1
Efficacy and Safety of Lenvatinib in Combination With Other Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma	1
Optimizing Natural Killer Cellular Therapy in Acute Myeloid Leukemia	1
Bevacizumab Combination Therapy Versus Standard Chemotherapy for Ovarian Cancer in Shorter and Longer Follow-Up Duration	1
Research Progress of SBRT Combined With Immunotherapy in Locally Advanced Head and Neck Cancer	1
Comprehensive Analysis of Conditional Survival in Radiation-treated Patients With Gynecologic Malignancies Using the SEER Database	1
AI Prognostication in Nonsmall Cell Lung Cancer	1
Letter to Editor on Qureshi et al. Efficacy and Safety of Abemaciclib in Combination with Endocrine Therapy for HR+/HER2− Advanced or Metastatic Breast Cancer a Systematic Review and Meta-Analysis, Am	1
Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non–Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant Chemoimmunotherapy	1
Nonoperative Management Following Complete Response in Rectal Cancer After Short-course Radiation Therapy and Consolidation Chemotherapy	1
Censoring Analysis of the INvestigating VorasiDenib In GliOma (INDIGO) Phase III Randomized Controlled Trial	1
Proceedings of the American Radium Society® 106th Annual Meeting	1
Outcomes of Patients With Esophageal and Gastric Carcinoma at a Safety-net Health Care System	1
ACR–ARS Practice Parameter for Communication	1
Relevance of Chemokines in Mobilizing γδ T Cells in the Biliary Tract Cancer Microenvironment: Potential for γδ T-Cell–Based Adoptive Cell Therapy	1
A Phase 2 Trial of Protein Kinase C Iota Inhibition With the Combination of Auranofin and Sirolimus in Patients With Recurrent Ovarian Cancer	1
A Review of Endocrine Therapy in Early-stage Breast Cancer	1
Bytes to Blood—Artificial Intelligence in the Management of Leukemia	1
Executive Summary of the American Radium Society Appropriate Use Criteria for Neoadjuvant Therapy for Nonmetastatic Pancreatic Adenocarcinoma	1
Rising Pancreatic Adenocarcinoma and Type 2 Diabetes Mellitus-Related Mortality in the United States, 2000 to 2024, With Forecasts to 2034	1
ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate Cancer	1
Advancements in Cutaneous T-Cell Lymphoma Treatment	1
Empowering Self-advocacy for Breast Health	1
Long-term Survival Among Patients With De Novo Human Epidermal Growth Receptor 2–Positive Metastatic Breast Cancer in Manitoba	1
Executive Summary of the American Radium Society Appropriate Use Criteria for the Use of Esophageal Stents in Patients With Esophageal Cancer	1
PARP Inhibitors in Newly Diagnosed and Recurrent Ovarian Cancer	1
Risk Factors for Recurrence and the Role of Radiotherapy in Low-grade Myofibroblastic Sarcoma	1
Modifiable Lifestyle Risk Factors in Adult Survivors of Childhood Cancer	1
Local Control Outcomes of Patients With Brain Metastases From Small Cell Lung Cancer Treated With Stereotactic Radiosurgery	1
Management Strategies and Outcomes in Primary Liver Angiosarcoma	1
Pretreatment Characteristics of Carcinoid Tumors of the Lung Which Predict Aggressive Behavior: Erratum	1
Effect of Somatosensory Interaction Transcutaneous Electrical Acupoint Stimulation on Cancer-related Fatigue and Immunity	1
Genetic Alterations in NSCLC	1
Predictors of Survival in Patients With Hepatocellular Cancer Receiving Atezolizumab and Bevacizumab	1
Conditional Survival Estimates for Malignant Glioma Patients	1
Stereotactic Radiosurgery for Vestibular Schwannoma With Radiographic Brainstem Compression	1
Risk Factors for Postoperative Venous Thromboembolism in Patients With Gynecologic Malignancies	1
Preliminary Analysis of Cervical Cancer Immunotherapy	1
Statewide Social Vulnerability Index (SVI) in Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma	1
Comparative Efficacy and Safety of Bispecific T-Cell Engagers (BiTEs) Versus Immune Checkpoint Inhibitors (ICIs) in Hematologic Malignancies	1
Predicting and Optimizing Synergistic Drug Combinations for Breast Cancer Treatment Using Machine Learning	1
Rituximab as a Therapeutic Strategy in Hemophagocytic Lymphohistiocytosis: Efficacy, Outcomes, and Survival—Insights From a Systematic Review	1
Performance Status and End-of-Life Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Androgen Receptor Targeted Therapy	1
Impact of Sequencing of Treatment Modalities on Survival in Nonmetastatic Hepatocellular Carcinoma	1
Real-world Outcomes Associated With Poly(ADP-ribose) Polymerase Inhibitor Monotherapy Maintenance in Patients With Primary Advanced Ovarian Cancer	1
Predictive Value of PIK3CA Mutations for Response to CDK4/6 Inhibitors in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer	1